Initial public offer of 51,48,800* equity shares of face value of Rs. 10.00 each ("Equity Shares") of Zenith Drugs Limited (the "Company" or the "Issuer") for cash at a price of Rs. 79.00 per equity share including a share premium of Rs. 69.00 per equity share (the "Issue Price") aggregating to Rs. 40.68 crores ("The Issue"). The issue includes a reservation of 8,52,800 equity shares aggregating to Rs. 6.74 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 42,96,000 equity shares aggregating to Rs. 33.94 crores (the "Net Issue"). The issue and the net issue constitute 30.02 % and 25.05 % respectively of the post issue paidup equity share capital of the company.
Face value of equity shares is Rs. 10.00 each and the issue price is 7.9 times of the face value.
Bid was made for minimum of 1,600 equity shares and the multiples of 1,600 equity shares thereafter
*Subject to finalization of basis of allotment
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
19-Feb-2024
22-Feb-2024
₹ 79.00
₹ 0.00
Minimum Application for shares in Nos : 1600.0
Further Multiples of : 1600.0
(₹)Cr.
Lead Managers to the Issue
Project Cost
35.96
Gretex Corporate Services Ltd
Project Financed through Current Offer
40.68
Post Issue Equity Share Capital
17.15
Issue Price
₹79.00
Projects
Purchase of Machinery & Equipments for Setting up new unit